WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Centessa Pharmaceuticals PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Antoine YverEVP Chairman of Development2023-06-016,500$4.45
$28.95kSell
Tia L. BushChief Quality Officer2023-05-243,000$4.48
$13.44kSell
Tia L. BushChief Quality Officer2023-05-245,000$4.49
$22.43kSell
Antoine YverEVP Chairman of Development2023-05-016,800$4.42
$30.08kSell
Antoine YverEVP Chairman of Development2023-04-036,700$3.69
$24.73kSell
David J. GraingerChief Innovation Officer2023-03-314,825$3.90
$18.82kSell
David M. ChaoChief Administrative Officer2023-03-316,969$3.90
$27.18kSell
Antoine YverEVP Chairman of Development2023-03-313,615$3.90
$14.10kSell
Thomas TemplemanChief Technology Officer2023-03-314,103$3.90
$16.00kSell
Saurabh SahaChief Executive Officer2023-03-3122,013$3.90
$85.85kSell

1 of 6

CNTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTA insiders and whales buy or sell their stock.

CNTA Shareholders

What type of owners hold Centessa Pharmaceuticals PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd20.98%19,963,157$89.83MInstitution
General Atlantic LP10.17%9,681,818$43.57MInstitution
Gap Bermuda Ltd10.17%9,681,818$43.57MInsider
Bvf Inc9.90%9,423,215$42.40MInstitution
Ecor1 Capital LLC5.90%5,618,779$25.28MInstitution
Vida Ventures Advisors LLC4.13%3,931,818$17.69MInstitution
Oup Management Co LLC3.09%2,937,615$13.22MInstitution
Price T Rowe Associates Inc2.43%2,313,433$10.41MInstitution
Point72 Asset Management LP1.87%1,775,482$7.99MInstitution
Samsara Biocapital LLC1.78%1,693,736$7.62MInstitution

1 of 3

CNTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTA70.29%14.96%Net SellingNet Selling
WVE62.03%37.97%Net Buying
ALVR14.07%85.93%Net BuyingNet Selling
ABUS20.67%79.33%
OMGA57.74%42.26%Net BuyingNet Selling
View Top Biotech Stocks

Centessa Pharmaceuticals Stock Ownership FAQ

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ: CNTA) is owned by 70.29% institutional shareholders, 14.96% Centessa Pharmaceuticals insiders, and 14.75% retail investors. Gap Bermuda Ltd is the largest individual Centessa Pharmaceuticals shareholder, owning 9.68M shares representing 10.17% of the company. Gap Bermuda Ltd's Centessa Pharmaceuticals shares are currently valued at $43.18M.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.